EP 2744484 A1 20140625 - PHARMACEUTICAL COMPOSITION COMPRISING 4-[4[[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYLAMINO]PHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE
Title (en)
PHARMACEUTICAL COMPOSITION COMPRISING 4-[4[[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYLAMINO]PHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT 4- [4-[4-CHLOR-3-(TRIFLUORMETHYL-)PHENYL-]CARBAMOYLAMIN-]PHENOXY-]N-METHYLPYRIDIN-2-CARBOXAMID
Title (fr)
COMPOSITION PHARMACEUTIQUE RENFERMANT DU 4-[4-[[4-CHLORO-3- (TRIFLUOROMÉTHYL)PHÉNYL]CARBAMOYLAMINO]PHÉNOXY]-N-MÉTHYLPYRIDINE-2- CARBOXAMIDE
Publication
Application
Priority
- EP 11177863 A 20110817
- US 201161524432 P 20110817
- EP 2012065513 W 20120808
- EP 12750726 A 20120808
Abstract (en)
[origin: EP2559431A1] The present invention relates to a pharmaceutical composition having a density of more than 1.55g/cm 3 in the form a tablet comprising 4-[4-[[4-chloro-3-(tifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide or a pharmaceutically acceptable salt thereof as active agent and at least one pharmaceutically acceptable excipient as well as a method of manufacturing such pharmaceutical composition.
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/44 (2006.01)
CPC (source: EP)
A61K 9/2009 (2013.01); A61K 31/44 (2013.01)
Citation (search report)
See references of WO 2013023970A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 2559431 A1 20130220; EP 2744484 A1 20140625; WO 2013023970 A1 20130221
DOCDB simple family (application)
EP 11177863 A 20110817; EP 12750726 A 20120808; EP 2012065513 W 20120808